Abstract
Brief Reports1 May 1980An Abnormal Lipoprotein in the Serum of Uremic Patients Maintained on Chronic HemodialysisNICHOLAS M. PAPADOPOULOS, Ph.D., WILLIAM Z. BORER, M.D., RONALD J. ELIN, M.D., Ph.D., LOUIS H. DIAMOND, M.D.NICHOLAS M. PAPADOPOULOS, Ph.D.Search for more papers by this author, WILLIAM Z. BORER, M.D.Search for more papers by this author, RONALD J. ELIN, M.D., Ph.D.Search for more papers by this author, LOUIS H. DIAMOND, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-92-5-634 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPremature coronary heart disease resulting from accelerated atherosclerosis ranks as a major cause of death among uremic patients who are undergoing chronic hemodialysis (1). Increased concentrations of serum triglycerides (2) and low serum concentrations of highdensity (HD) lipoprotein-cholesterol have been reported in patients with end-stage renal disease treated with chronic maintenance hemodialysis (3, 4). The authors of these reports have suggested that the premature cardiovascular morbidity and mortality seen in this group of patients may be due to the decreased serum concentration of HD lipoprotein or an abnormal biochemical composition of the lipoproteins.We report here the analysis of serum...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
